Thursday, April 01, 2021 3:46:02 PM
December 17, 2020 Resonate Blends, Inc. (OTCQB:KOAN), a cannabis-based holding company ("Resonate" or "the Company"), today provides an update to shareholders on several topics relating to the launch of its first value-added Cannabis Brand with the industry’s first line of THC-based Koan Cordials.
Dear Shareholders,
We are pleased to announce we have begun the process of executing on the launch of our innovative Koan Cordials (www.koan.life), which will ship in first quarter of next year. KOAN® is the brand name for our first family of cannabis products targeting the Wellness Lifestyle market.
Our tagline is "Mastering the Art of Experience," which is our goal across our entire line of products starting with our first 6 cannabis experience-based Cordial products. Cordials are uniquely formulated, single serving precisely targeted experiences that are directly ingested or mixed with a drink of your choice for use in social or private settings. We were always looking for a product like this, and we could never find it - so we made it.
Everything from ordering inventory, opening up distribution channels and final preparation for our marketing efforts are now underway. We believe value-added brands focused on experience targets represent the greatest market opportunity in the maturing cannabis market. Our mission is to demystify and normalize cannabis use through innovative products built around the healing powers of plant medicine. Cordials are the first in a family of products designed around our unique Resonate System---the heart of our product development process.
We are in early discussions to license our products in two other cannabis friendly states, and we hope to have further updates on this new potential revenue stream once we launch our Cordials in California.
Dear Shareholders,
We are pleased to announce we have begun the process of executing on the launch of our innovative Koan Cordials (www.koan.life), which will ship in first quarter of next year. KOAN® is the brand name for our first family of cannabis products targeting the Wellness Lifestyle market.
Our tagline is "Mastering the Art of Experience," which is our goal across our entire line of products starting with our first 6 cannabis experience-based Cordial products. Cordials are uniquely formulated, single serving precisely targeted experiences that are directly ingested or mixed with a drink of your choice for use in social or private settings. We were always looking for a product like this, and we could never find it - so we made it.
Everything from ordering inventory, opening up distribution channels and final preparation for our marketing efforts are now underway. We believe value-added brands focused on experience targets represent the greatest market opportunity in the maturing cannabis market. Our mission is to demystify and normalize cannabis use through innovative products built around the healing powers of plant medicine. Cordials are the first in a family of products designed around our unique Resonate System---the heart of our product development process.
We are in early discussions to license our products in two other cannabis friendly states, and we hope to have further updates on this new potential revenue stream once we launch our Cordials in California.
Recent KOAN News
- Apollo Biowellness, Inc., Update of Take-Over by MedwellAI, Inc. • Newsfile • 04/08/2026 01:30:00 PM
- MedWell Ai Executes Letter Of Intent To Create America's First Vertically Integrated Regenerative Wellness Eco-System • GlobeNewswire Inc. • 02/10/2026 03:08:32 PM
- Apollo Biowellness Executes Letter Of Intent with Medwell AI, Inc. • Newsfile • 02/10/2026 02:30:00 PM
- Apollo Biowellness, Inc., Announces Termination of Distribution Agreement with Revive Regenerative, Inc. • Newsfile • 02/06/2026 02:30:00 PM
- Apollo Biowellness, Inc., Announces Expiration of Letter of Intent, Negotiations Continue • Newsfile • 01/07/2026 02:30:00 PM
- Apollo Biowellness, Inc., Corporate Status and Merger Update • Newsfile • 10/29/2025 01:30:00 PM
- Apollo Biowellness, Inc., Merger Update • Newsfile • 10/09/2025 06:48:00 PM
- Apollo Biowellness, Inc., Re-Engages GSS Capital • Newsfile • 10/08/2025 01:30:00 PM
- Form 15-12G/A - Securities registration termination [Section 12(g)]: [Amend] • Edgar (US Regulatory) • 07/22/2025 05:22:28 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 07/07/2025 05:36:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/16/2025 08:28:57 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/10/2025 03:41:27 PM
